Akut Koroner Sendromlu Hastalarda Kardiyak Rehabilitasyon

Kardiyak rehabilitasyon (KR), akut koroner sendromu olan kişilerin, optimal fiziksel, mental, medikal, kavuşabilmelerini ve bu iyilik halinin sürdürülmesini amaçlayan bir süreçtir. Yapılan birçok çalışma ile bu fayda gösterilmiştir. Akut koroner sendromu (AKS), kararsız anjin, ST-segment yükselmesi olan ve olmayan miyokard infarktüsünü kapsayan, tedavisinde büyük gelişmeler olmasına rağmen yüksek morbidite ve mortalite sebebi olan yaygın bir hastalıktır. Bu hastalara uygulanan KR tedavisi ile morbidite ve mortalitede önemli düzeyde azalma sağlanır. AKS sonrası uygulanan KR ile hastayı iyileştirmek ve bu iyilik halinin devam ettirilerek yeni kardiyak olay gelişimi önlenmesi amaçlanır. Fakat bu yararlı etkilerine rağmen KR'a katılan hasta sayısı çok sınırlı kalmaktadır

Cardiac Rehabilitation in Patients with Acute Coronary Syndrome

Cardiac rehabilitation (CR) is the process by which patients with acute coronary syndrome are restored to and maintained at their physiological, psychological, social, sexual, emotional and vocational status. The benefits of CR have been demonstrated in a number of studies. Acute coronary syndromes (ACS), which include unstable angina and myocardial infarction with or without ST-segment elevation, are life-threatening and most common disorders that remain a source of high morbidity and mortality despite advances in treatment. CR participation is associated with a markedly reduced of morbidity and mortality after ACS. Cardiac rehabilitation is offered to individuals after ACS to aid recovery and reduce the likelihood of further cardiac illness. However, despite the proven benefits of CR services, only a minority of eligible patients receive these services

___

  • 1. Saczynski JS, Lessard D, Spencer FA, Gurwitz JH, Gore JM, Yarzebski J, Goldberg RJ. Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. Am J Med. 2010;123(11):1007-15.
  • 2. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44-122.
  • 3. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey Jr DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS. 2011 ACCF/AHA focused update incorporated into the acc/aha 2007 guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;57(19):e215-367.
  • 4. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr, Anbe DT, Kushner FG, Ornato JP, Pearle DL, Sloan MA, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With STElevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008;117(6):e162.
  • 5. Lee HY, Cooke CE, Robertson TA. Use of secondary prevention drug therapy in patientswith acute coronary syndrome after hospital discharge J Manag Care Pharm. 2008;14(3):271-80.
  • 6. Kottke TE, Faith DA, Jordan CO, Pronk NP, Thomas RJ, Capewell S. The comparative effectiveness of heart disease prevention and treatment strategies. Am J Prev Med. 2009;36(1):82-8.
  • 7. Organization WH. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. W Press. 2007.
  • 8. Iestra JA, Kromhout D, van der Schouw YT, Grobbee DE, Boshuizen HC, van Staveren WA. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005;112(6):924-34.
  • 9. Fletcher BJ, RN, MN, Lloyd A, Fletcher GF. Outpatient rehabilitative training in patients with cardiovascular disease: Emphasis on training method. Heart Lung. 1988;17(2):199-205.
  • 10. Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J. 2008;156(1):31-6.
  • 11. Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, Franklin B, Sanderson B, Southard D. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update. Circulation. 2007;115(20):2675-82.
  • 12. Costa F, Ariotti S, Valgimigli M, Kolh P, Windecker S; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization: Fifty Years of Revascularization: Where Are We and Where Are We Heading? J Cardiovasc Transl Res. 2015;8(4):211-20.
  • 13. Thomas RJ, Denna T. The role of cardiac rehabilitation following acute coronary syndromes. Curr Cardiol Rep. 2014;16(10):534.
  • 14. Kim C, Jung H, Choi HE, Kang SH. Cardiac rehabilitation after acute myocardial infarction resuscitated from cardiac arrest. Ann Rehabil Med. 2014;38(6):799-804.
  • 15. Sunamura M, Ter Hoeve N, van den Berg-Emons HJ, Haverkamp M, Redekop K, Geleijnse ML, Stam HJ, Boersma E, van Domburg RT. OPTImal CArdiac REhabilitation (OPTICARE) following Acute Coronary Syndromes: Rationale and design of a randomised, controlled trial to investigate the benefits of expanded educational and behavioural intervention programs. Neth Heart J. 2013;21(7-8):324- 30.
  • 16. Lee HY, Kim JH, Kim BO, Byun YS, Cho S, Goh CW, Ahn H, Rhee KJ, Kim C. Regular exercise training reduces coronary restenosis after percutaneous coronary intervention in patients with acute myocardial infarction. Int J Cardiol. 2013;167(6):2617-22.
  • 17. Piepoli MF, Davos C, Francis DP, Coats AJ; ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ. 2004;328(7433):189.
Medicine Science-Cover
  • ISSN: 2147-0634
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2012
  • Yayıncı: Effect Publishing Agency ( EPA )